3rd Drug Formulation & Bioavailability brings together the industry's leading formulation experts together to share and discuss emerging drug bioavailability and solubility enhancement strategies. More than 150 executives from 90+ leading organizations will discuss and hear unique take-home examples, case studies and multiple formulation and preformulation strategies to assist in improving drug solubility and bioavailability, maximizing exposure, and reducing time-to-market on future drug products. Both Capsugel and Bend Research will have a booth at this event. Capsugel will feature a presentation from Eduardo Jule, PhD, on January 28th at 11:30 AM titled, "Reducing Development Timelines and Cost of Lipid-Based Drug Delivery". Bend Research's Vice President, David Vodak, PhD, will present on January 29th at 3:20 PM on "Practical Aspects of Spray Dried Dispersions: Performance, Manufacture and Stability".
Please note that Lonza has updated its Privacy Policy. By visiting our website or using services provided by Lonza, you are accepting the practices described in the Privacy Policy.
We also use cookies on our websites. Cookies allow us to give you the best browsing experience and help us to understand how you use our site. You can disable cookies but parts of our website may not work. Please read our updated Cookies Policy for information about which cookies we use and the information we collect. By continuing to use this website, you agree that we may store and access cookies on your device.
By clicking "I Agree", you confirm that you are above the age of 16, that you have read and understood the Privacy Policy and the Cookies Policy, and that you agree to the collection, use and processing of your Personal Information by Lonza in accordance with said policies.